Syneos Health (formerly INC Research) VP of Product Salaries in Baltimore, MD
The average Syneos Health (formerly INC Research) VP of Product in Baltimore, MD earns an estimated $241,210 annually, which includes an estimated base salary of $191,890 with a $49,320 bonus. Syneos Health (formerly INC Research) VP of Product compensation is $112,759 less than the US average for a VP of Product. VP of Product salaries at Syneos Health (formerly INC Research) in Baltimore, MD can range from $125,599 - $433,000.
In Baltimore, MD, The Product Department at Syneos Health (formerly INC Research) earns $15,119 more on average than the Sales Department.
Last updated 21 days ago.
- $191,890
- avg. base
- $49,320
- avg. bonus
VP of Product Salaries at Syneos Health (formerly INC Research)
In Baltimore, MD, VPs of Product earn $16,545 more than Group Product Managers.
Compensation at Syneos Health (formerly INC Research) by Department
In Baltimore, MD, The Product Department averages $15,119 more than the Sales Department, and $8,139 less than the Enterprise Risk Department
VP of Product Compensation by Gender (All Companies)
The average female VP of Product at companies similar size to Syneos Health (formerly INC Research) reported making $279,465, while the average male VP of Product at similar sized companies reported making $259,922.
VP of Product Compensation by Ethnicity (All Companies)
The average Hispanic or Latino VP of Product at companies similar size to Syneos Health (formerly INC Research) reported making $282,500, while the average African American/Black VP of Product at similar sized companies reported making $238,500.
How VPs of Product at Syneos Health (formerly INC Research) Rate Their Compensation
The majority of VPs of Product at Syneos Health (formerly INC Research) believe they're compensated fairly. 100% of VPs of Product at Syneos Health (formerly INC Research) say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at Syneos Health (formerly INC Research)
